Scientists foresee Russian gene therapy for HIV cure may be registered in 5-10 yearsTASSMOSCOW, August 17. /TASS/. A Russian gene therapy drug for individuals infected with HIV called Dinavir is undergoing pre-clinical trials, and the drug has already … Continue reading
NormanObserver.com |
Abeona Therapeutics Announces Pivotal Expansion Of Gene Therapy Trials In Sanfilippo Syndrome Type A
Clinical Leader Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, recently announced the pivotal expansion of its gene therapy clinical trials for patients with … Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome …London South East (registration) (blog) Abeona Therapeutics Inc. (ABEO) Issues Earnings ResultsBNB Daily (blog) What Next for Abeona Therapeutics Inc (ABEO) Stock After Today’s Big Increase?Press Telegraph Transcript Daily –Herald KS all 27 news articles » |
Medical Xpress |
Are stem cells the link between bacteria and cancer?
Medical Xpress An interdisciplinary research team at the Max Planck Institute in Berlin in collaboration with researchers in Stanford, California, has now discovered that the bacterium sends stem cell renewal in the stomach into overdrive – and stem cell turnover has … |
|
Synthetic Biology Market to Grow Rapidly Worldwide till 2024 Owing …
MENAFN.COM (MENAFN Editorial) Synthetic Biology Market Size, Application Analysis, Share, Growth, Trends, Regional Outlook, Competitive Strategies and Forecasts, 2016 … Global Synthetic Biology Market Research Report 2016 – satPRnewssatPRnews (press release) Synthetic Biology Market Size, Analysis, and Forecast Report 2016 …Medgadget (blog) |
Technology Networks |
World Vaccine & Immunotherapy Congress West Coast
Technology Networks Following a hugely successful World Vaccine Congress in Washington in April we’re bringing the World Vaccine & Immunotherapy Congress to San Diego from Nov 30 – Dec 1 where we’ll be integrating the technologies revolutionising immunotherapy and its … |
San Francisco Chronicle |
10-year, $1B life sciences plan bears fruit in Massachusetts
San Francisco Chronicle In this Monday, Aug. 14, 2017 photo, researcher Leonard Zon, founder and director of the Stem Cell Program at Boston Children’s Hospital, stands for a photograph among rows of containers holding about 300,00 zebrafish in a lab at the hospital, in Boston. |